再生障碍性贫血(以下简称再障)是由多种因素所致的以骨髓脂肪化、三系细胞减少为主要特征的造血功能障碍的一种综合征。多年来,再障治疗缺乏可行有效的治疗方法,因而本病病死率颇高。50年代,多数患者靠输血维持生命、仅有少数病例自然缓解及延长存活期。60年代以来,由于雄激素类药物的广泛应用以及中医中药和中西医结合临床实验研究的不断探索,慢性再障(CAA)取得了突破性进展,使30～40% Aplastic anemia (hereinafter referred to as aplastic anemia) is caused by a variety of factors to bone marrow fatty, three-line cell reduction as the main feature of a syndrome of hematopoietic dysfunction. Over the years, aplastic anemia treatment lack of feasible and effective treatment, so the disease fatality rate is high. In the 1950s, most patients survived with blood transfusions and only a few natural relief and prolonged survival were achieved. Since the 1960s, due to the extensive application of androgenic drugs and the continuous exploration of traditional Chinese medicine and clinical trials of integrated traditional and western medicine, breakthroughs have been made in the treatment of chronic aplastic anemia (CAA). 30 to 40%